Charles River Associates (CRAI)
(Real Time Quote from BATS)
$166.56 USD
-1.14 (-0.68%)
Updated Sep 20, 2024 12:24 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
Charles River Associates - Buy
Zacks' proprietary data indicates that Charles River Associates is currently rated as a Zacks Rank 1 and we are expecting an above average return from the CRAI shares relative to the market in the next few months. In addition, Charles River Associates has a VGM Score of B (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that Charles River Associates may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of CRAI, demonstrate its potential to perform inline with the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.
Style Scorecard
Value Scorecard
Growth Scorecard
Momentum Scorecard
Value Score | CRAI: C | Industry [X] | EXPO: F | HCKT: C | III: A |
---|---|---|---|---|---|
Zacks Rank | 1 | 2 | 4 | 3 | |
VGM Score | B | C | A | A | |
Cash/Price | 0.02 | 0.03 | 0.04 | 0.03 | 0.08 |
EV/EBITDA | 13.58 | 14.23 | 37.74 | 14.23 | 10.34 |
PEG Ratio | 1.51 | 1.23 | NA | 1.23 | 1.02 |
Price/Book (P/B) | 5.93 | 4.24 | 14.42 | 7.26 | 1.66 |
Price/Cash Flow (P/CF) | 17.95 | 18.05 | 51.76 | 20.48 | 8.23 |
P/E (F1) | 24.21 | 25.53 | 54.78 | 17.23 | 14.82 |
Price/Sales (P/S) | 1.74 | 2.00 | 10.47 | 2.45 | 0.60 |
Earnings Yield | 4.13% | 3.85% | 1.83% | 5.80% | 6.75% |
Debt/Equity | 0.00 | 0.26 | 0.00 | 0.26 | 0.78 |
Cash Flow ($/share) | 9.34 | 2.23 | 2.16 | 1.31 | 0.40 |
Growth Score | CRAI: B | Industry [X] | EXPO: A | HCKT: A | III: B |
---|---|---|---|---|---|
Zacks Rank | 1 | 2 | 4 | 3 | |
VGM Score | B | C | A | A | |
Hist. EPS Growth | 17.75% | 17.75% | 7.37% | 19.41% | 16.69% |
Proj. EPS Growth | 26.88% | 7.35% | 5.15% | 0.65% | -45.00% |
Curr. Cash Flow Growth | -6.89% | 1.54% | -0.14% | -13.41% | -29.72% |
Hist. Cash Flow Growth | 13.96% | 10.30% | 8.04% | -1.85% | 0.54% |
Current Ratio | 1.07 | 1.69 | 2.97 | 1.71 | 2.14 |
Debt/Capital | 0.00% | 20.74% | 0.00% | 20.74% | 43.71% |
Net Margin | 6.17% | 6.34% | 19.35% | 11.46% | -0.38% |
Return on Equity | 22.37% | 18.39% | 28.39% | 38.20% | 7.48% |
Sales/Assets | 1.19 | 1.09 | 0.84 | 1.66 | 1.11 |
Proj. Sales Growth (F1/F0) | 8.13% | 5.42% | 3.82% | 3.14% | -10.85% |
Momentum Score | CRAI: C | Industry [X] | EXPO: F | HCKT: B | III: B |
---|---|---|---|---|---|
Zacks Rank | 1 | 2 | 4 | 3 | |
VGM Score | B | C | A | A | |
Daily Price Chg | 0.30% | 0.30% | 3.00% | 1.13% | -1.21% |
1 Week Price Chg | 3.68% | 1.21% | 6.22% | 7.01% | 3.16% |
4 Week Price Chg | 4.54% | 2.54% | 7.77% | 4.43% | -1.21% |
12 Week Price Chg | -3.56% | 4.47% | 16.87% | 24.73% | 6.19% |
52 Week Price Chg | 61.79% | 14.76% | 27.52% | 15.76% | -26.41% |
20 Day Average Volume | 27,910 | 73,899 | 193,271 | 114,811 | 71,627 |
(F1) EPS Est. Wkly Chg | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
(F1) EPS Est. Mthly Chg | 2.71% | 0.00% | 0.00% | 0.00% | 5.00% |
(F1) EPS Est. Qtrly Chg | 11.96% | 0.12% | 5.97% | -0.39% | -14.29% |
(Q1) EPS Est. Mthly Chg | 3.78% | 0.00% | 0.00% | 0.00% | 0.00% |
Zacks News for CRAI
Multi-Channel Approach Benefits CPAY Amid Declining Liquidity
CRAI: What are Zacks experts saying now?
Zacks Private Portfolio Services